GUIDELINES

Apuntes

GUIDELINES AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis Siddharth Singh, 1,2 Edward V. Loftus Jr, 3 Berkeley N. Limketkai, 4 John P. Haydek, 5,6 Manasi Agrawal, 7,8 Frank I. Scott, 9 and Ashwin N. Ananthakrishnan, 10,11 on behalf of the AGA Clinical Guidelines Committee 1 Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California; 2 Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, La Jolla, California; 3 Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota; 4 Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles, School of Medicine, Los Angeles, California; 5 Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 6 Multidisciplinary Center for In fl ammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 7 The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New...